-Outlook The Maoists want a military conflict as it brings more adivasis into their fold. The Indian state's best bet is in ensuring that it wins over the aam adivasis to its side.   May 25th's condemnable attack by the People's Liberation Guerrilla Army, which ended up killing and injuring over 50 people from Congress politicians to migrant adivasi labourers, cannot be understood without recognising the Maoist party's explicit political aims. These...

-The Hindu   With her passing, Indian feminism has lost one of its earliest icons Three years ago, almost to the day, when we launched Vina Mazumdar's memoir, Memories of a Rolling Stone, the room at the Habitat Centre in Delhi was packed to overflowing. Resplendent in her beautiful silk, Vinadi, as she was known to everyone around her, smiled her way through the evening as bureaucrats, academics, politicians, educationists, feminists and others...

-The Economic Times NEW DELHI: Petrol could become costlier by about 4 a litre if the government compels oil firms to sell 5% ethanol-blended petrol across the country by next month as these companies would be forced to import huge quantities of the biofuel at exorbitant rates. But, the Cabinet, which will meet soon to discuss the issue, may relax compulsory doping as it would want petrol prices to rise sharply, months...

-The Telegraph Hyderabad: As rights groups accused the anti-Maoist militia Salwa Judum of atrocities on Chhattisgarh's villagers, its founder Mahendra Karma kept insisting his only aim was to "liberate" the tribals from the rebels' tyranny and propaganda. The future of the government-backed vigilante group, which still survives unofficially despite a Supreme Court order to disband it, now looks bleak after the Maoists killed Congress tribal leader Karma yesterday. The Salwa Judum (whose name...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...